Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of the Health Information Needs of Brain Cancer Patients

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT01130220
First received: May 24, 2010
Last updated: July 24, 2012
Last verified: July 2012
  Purpose

The purpose of this research is to explore the factors involved in brain cancer health care literacy needs.


Condition Intervention
Brain Tumor
Other: Focus Group

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Informed Brain Cancer Patients

Resource links provided by NLM:


Further study details as provided by University of Florida:

Primary Outcome Measures:
  • Explore the factors involved in health care literacy from the perspective of brain cancer patients. [ Time Frame: 1 Year ] [ Designated as safety issue: No ]
    An investigator experienced in semi-structured focus group research will faclitate focus group sessions by using a generalized list of topics and open-ended discussion questions.


Secondary Outcome Measures:
  • Explore the factors involved in health care literacy from the perspective of health care providers. [ Time Frame: 1 Year ] [ Designated as safety issue: No ]
    An investigator experienced in semi-structured focus group research will faclitate focus group sessions by using a generalized list of topics and open-ended discussion questions.


Enrollment: 27
Study Start Date: May 2010
Study Completion Date: December 2011
Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Brain Tumor Patient
A one-time focus group will be held in a quiet room for approximately 30-60 minutes until a "saturation" of themes has been identified.
Other: Focus Group
A single focus group will be held until a "saturation" of themes has been identified.
Health Care Provider
A one-time focus group will be held in a quiet room for approximately 30-60 minutes until a "saturation" of themes has been identified.
Other: Focus Group
A single focus group will be held until a "saturation" of themes has been identified.

Detailed Description:

A mere subset of the reasons behind unmet health care literacy needs include the health care systems' increasing complexity, increased time constraints, profound treatment decision making requirements, decreased financial resources, fracturing social networks and diversifying educational and cultural needs.

This project will use focus groups to explore the factors involved in brain cancer health care literacy from the perspectives of patients and those involved in their care. Hypothesis generated from this project will be directly applied toward future projects. The overarching goals are improved access and adequacy of health care literacy information through the eventual development of validated, useful, reliable health care literacy information tools for brain cancer patients and those involved in their care.

  Eligibility

Ages Eligible for Study:   18 Years to 89 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Participants will be recruited during routine interactions with the investigators.

Criteria

Inclusion Criteria:

BRAIN TUMOR PATIENTS:

  • 18 to 89 years of age
  • Have or have had any type of brain tumor
  • Ability to communicate in English
  • Willingness to participate in a 30-60 minute focus group

HEALTH CARE PROVIDERS:

  • 18 to 89 years of age
  • Be a health care provider who cares for any type of brain tumor
  • Ability to communicate in English
  • Willingness to participate in a 30-60 minute focus group

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01130220

Locations
United States, Florida
University of Florida
Gainesville, Florida, United States, 32610
Sponsors and Collaborators
University of Florida
Investigators
Principal Investigator: Erin M Dunbar, MD University of Florida
  More Information

No publications provided

Responsible Party: University of Florida
ClinicalTrials.gov Identifier: NCT01130220     History of Changes
Other Study ID Numbers: 708-2009
Study First Received: May 24, 2010
Last Updated: July 24, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Florida:
Brain Tumor
Brain Neoplasm

Additional relevant MeSH terms:
Brain Neoplasms
Brain Diseases
Central Nervous System Diseases
Central Nervous System Neoplasms
Neoplasms
Neoplasms by Site
Nervous System Diseases
Nervous System Neoplasms

ClinicalTrials.gov processed this record on November 20, 2014